Haiyan Liao

发表

Hsa_circ_0074158 regulates the endothelial barrier function in sepsis and its potential value as a biomarker

Y. Chai, Z. Wang, Zhong Wang, 2022, Frontiers in Genetics.

Diagnostic and predictive values of pyroptosis-related genes in sepsis

F. Chen, Z. Wang, Zhong Wang, 2023, Frontiers in Immunology.

Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway

Zhong Wang, Zhe Guo, Yanting Chai, 2022, Cells.

Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis

F. Chen, Zhong Wang, Zhe Guo, 2022, Frontiers in Pharmacology.

A new perspective on the potential application of RIPK1 in the treatment of sepsis.

Y. Chai, Z. Wang, Zhong Wang, 2023, Immunotherapy.

Reduning Attenuates LPS-Induced Human Unmilical Vein Endothelial Cells (HUVECs) Apoptosis Through PI3K-AKT Signaling Pathway

Y. Chai, Z. Wang, Zhong Wang, 2022, Frontiers in Pharmacology.

In silico high-throughput screening system for AKT1 activators with therapeutic applications in sepsis acute lung injury

Y. Chai, Zhong Wang, Zhe Guo, 2022, Frontiers in Cellular and Infection Microbiology.

Reduning alleviates sepsis-induced acute lung injury by reducing apoptosis of pulmonary microvascular endothelial cells

F. Chen, Z. Wang, Zhong Wang, 2023, Frontiers in Immunology.

Application Prospect of the SOFA Score and Related Modification Research Progress in Sepsis

Z. Wang, Zhong Wang, Zhe Guo, 2023, Journal of clinical medicine.